Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 May 1:6:331-53.
doi: 10.2147/JPR.S42040. Print 2013.

Consequences of the 118A>G polymorphism in the OPRM1 gene: translation from bench to bedside?

Elisa Mura  1 , Stefano Govoni, Marco Racchi, Valeria Carossa, Guglielmina Nadia Ranzani, Massimo Allegri, Ron Hn van Schaik
Affiliations

Consequences of the 118A>G polymorphism in the OPRM1 gene: translation from bench to bedside?

Elisa Mura et al. J Pain Res. .

Abstract

The 118A>G single nucleotide polymorphism (SNP) in the μ-opioid receptor (OPRM1) gene has been the most described variant in pharmacogenetic studies regarding opioid drugs. Despite evidence for an altered biological function encoded by this variant, this knowledge is not yet utilized clinically. The aim of the present review was to collect and discuss the available information on the 118A>G SNP in the OPRM1 gene, at the molecular level and in its clinical manifestations. In vitro biochemical and molecular assays have shown that the variant receptor has higher binding affinity for β-endorphins, that it has altered signal transduction cascade, and that it has a lower expression compared with wild-type OPRM1. Studies using animal models for 118A>G have revealed a double effect of the variant receptor, with an apparent gain of function with respect to the response to endogenous opioids but a loss of function with exogenous administered opioid drugs. Although patients with this variant have shown a lower pain threshold and a higher drug consumption in order to achieve the analgesic effect, clinical experiences have demonstrated that patients carrying the variant allele are not affected by the increased opioid consumption in terms of side effects.

Keywords: analgesia; opioids; pain; pharmacogenetics; μ-opioid receptor.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Consequences of OPRM1 118A>G SNP. Abbreviations: mRNA, messenger RNA; SNP, single nucleotide polymorphism.
See this image and copyright information in PMC

References

    1. Benyamin R, Trescot AM, Datta S, et al. Opioid complications and side effects. Pain Physician. 2008;11(Suppl 2):S105–S120. - PubMed
    1. Højsted J, Sjøgren P. Addiction to opioids in chronic pain patients: a literature review. Eur J Pain. 2007;11(5):490–518. - PubMed
    1. Slatkin NE. Opioid switching and rotation in primary care: implementation and clinical utility. Curr Med Res Opin. 2009;25(9):2133–2150. - PubMed
    1. Zacny JP, Lichtor JL, Flemming D, Coalson DW, Thompson WK. A dose-response analysis of the subjective, psychomotor and physiological effects of intravenous morphine in healthy volunteers. J Pharmacol Exp Ther. 1994;268(1):1–9. - PubMed
    1. Glare PA, Walsh TD. Clinical pharmacokinetics of morphine. Ther Drug Monit. 1991;13(1):1–23. - PubMed